Table 2 Change of NLR and PLR at diagnosis, after one cycle chemotherapy, and at progression

From: The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer

Value

At diagnosis

After one cycle of chemotherapy

P

After 1 cycle of chemotherapy

At progression

P

NLR, mean±s.d.

3.78±3.13

2.63±2.80

<0.001

2.63±2.80

4.50±6.37

<0.001

PLR, mean±s.d.

183.16±98.21

173.16±119.93

0.01

173.16±119.93

181.69±143.11

0.518

  1. Abbreviations: NLR=neutrophil-lymphocyte ratio; PLR=platelet-lymphocyte ratio; s.d.=standard deviation.
Back to article page